Conference abstractPublished 2018
Modified release of Diclofenac Sodium from compression-coated tablets
University College London, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diclofenac Sodium is a nonsteroidal anti-inflammatory drug taken or applied to reduce inflammation and pain in certain conditions. Its gastrointestinal adverse effects include persistent nausea/vomiting, loss of appetite, stomach/ abdominal pain, etc. and can be eliminated by the modification of the drug release from the pharmaceutical dosage forms. The aim of this work is to develop and evaluate diclofenac sodium compression coated tablets using different types of Eudragit®.The dissolution experiments involved tablets that were comprised of Diclofenac Sodium, Lactose monohydrate (core) and different types of Eudragit® (coating), and were prepared by direct compression. Their drug release in gastric and intestinal simulated fluids, was determined spectrophotometrically at λmax=276 nm.The results from the in vitro release experiments suggest that the compression coated tablets composition used in this work constitute promising drug delivery systems for the modified release of per os administered Diclofenac Sodium.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Sciences & Emerging Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sofia Konstantinidou”
